Piramal Critical Care and Blue-Zone Technologies Partner to Recycle Waste Anaesthesia Gas

Bethlehem, February 06, 2026: Piramal Critical Care, Inc., an overseas subsidiary of Piramal Pharma Limited, has entered into a collaboration with Blue-Zone Technologies Ltd. to deploy a full-lifecycle solution for capturing, collecting, and recycling waste anaesthetic gases.

The collaboration brings together Blue-Zone’s proprietary technology for waste anaesthesia gas capture and processing with Piramal Critical Care’s global manufacturing and commercial capabilities. The initiative aims to help healthcare providers reduce the environmental impact of volatile anaesthetics while ensuring continued access to clinically essential inhaled anaesthesia products.

Subject to regulatory approval in Europe, Blue-Zone’s Phoenix Deltasorb® waste anaesthetic gas capture system will be offered to Piramal Critical Care’s customers, initially in France and Germany. Blue-Zone will manage the supply, installation, and use of the systems within healthcare facilities. Piramal Critical Care will process the captured waste anaesthetic gases using Blue-Zone’s technology to produce Sevoflurane USP for human use at its facilities in Canada.

The companies indicated that the collaboration may expand to additional geographies over time, covering both the recycling of waste anaesthetic gases and the marketing of Sevoflurane USP derived from recovered materials.

Jeff Hampton, President and COO, Piramal Critical Care, said, “Piramal Critical Care is proud to partner with Blue-Zone on this innovative waste anaesthetic gas capture, collection, and recycling technology to help reduce waste and minimize environmental impact. By introducing gas capture technology, hospitals can choose the inhaled anaesthetic that best meets clinical needs while also supporting more sustainable healthcare goals.

“Inhaled anaesthetics are vitally important medicines that enable essential treatment for patients around the world. As a leading global manufacturer of general anaesthesia products, Piramal Pharma is committed to supporting clinicians, hospitals, and health systems with solutions that balance clinical performance and environmental responsibility. Our focus is to ensure that patients continue to receive the critical care they need while advancing more sustainable approaches to anaesthesia.”

The collaboration reflects growing efforts within the healthcare sector to address emissions and waste associated with anaesthetic gases, while maintaining patient safety and continuity of care.